FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102561304> ?p ?o ?g. }

• W2102561304 endingPage "750" @default.
• W2102561304 startingPage "741" @default.
• W2102561304 abstract "We have studied the molecular basis of resistance of multiple human leukaemia CCRF-CEM sublines to the novel antifolates ZD9331, GW1843, AG2034, PT523 and edatrexate, which use the reduced folate carrier (RFC) as their main cellular uptake route and that target different folate-dependent enzymes. Antifolate-resistant sublines established by stepwise and single-step selections displayed up to 2135-fold resistance to the selection drug, and up to 2323-fold cross-resistance to various hydrophilic antifolates. In contrast, these sublines were up to 17- and 20-fold hypersensitive to the lipophilic antifolates AG377 and trimetrexate, respectively. The total reduced folate pool of these antifolate-resistant sublines shrunk by 87-96%, resulting in up to 42-fold increased folic acid growth requirement. These sublines lost 92-97% of parental [(3)H]methotrexate influx rates. Genomic PCR single-strand conformational polymorphism analysis and sequencing revealed that most of these drug-resistant sublines harboured RFC mutations that surprisingly clustered in two confined regions in exons 2 and 3. The majority of these mutations resulted in frame-shift and/or premature translation termination and lack of RFC protein expression. The remaining mutations involved single amino acid substitutions predominantly residing in the first transmembrane domain (TMD1). Some RFC-inactivating mutations emerged during the early stages of antifolate selection and were stably retained during further drug selection. Furthermore, some sublines displayed a markedly decreased or abolished RFC mRNA and/or protein expression. This constitutes the first demonstration of clustering of multiple human RFC mutations in TMD1, thereby suggesting that it plays a functional role in folate/antifolate binding and/or translocation. This is the first molecular characterization of human RFC-associated modalities of resistance to various novel antifolates in multiple leukaemia sublines." @default.
• W2102561304 created "2016-06-24" @default.
• W2102561304 creator A5000430366 @default.
• W2102561304 creator A5007946879 @default.
• W2102561304 creator A5013852274 @default.
• W2102561304 creator A5049208861 @default.
• W2102561304 creator A5066790265 @default.
• W2102561304 creator A5086799202 @default.
• W2102561304 date "2002-11-01" @default.
• W2102561304 modified "2023-09-30" @default.
• W2102561304 title "Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines" @default.
• W2102561304 cites W1493877135 @default.
• W2102561304 cites W1512597168 @default.
• W2102561304 cites W1517703555 @default.
• W2102561304 cites W1518525144 @default.
• W2102561304 cites W1562169645 @default.
• W2102561304 cites W1573184761 @default.
• W2102561304 cites W1591370090 @default.
• W2102561304 cites W1601021719 @default.
• W2102561304 cites W1896127315 @default.
• W2102561304 cites W1911881343 @default.
• W2102561304 cites W1965201843 @default.
• W2102561304 cites W1978667402 @default.
• W2102561304 cites W1980003414 @default.
• W2102561304 cites W2001731555 @default.
• W2102561304 cites W2006448792 @default.
• W2102561304 cites W2012459434 @default.
• W2102561304 cites W2019995269 @default.
• W2102561304 cites W2021158571 @default.
• W2102561304 cites W2025660630 @default.
• W2102561304 cites W2032736075 @default.
• W2102561304 cites W2052177287 @default.
• W2102561304 cites W2061419578 @default.
• W2102561304 cites W2067267161 @default.
• W2102561304 cites W2069418933 @default.
• W2102561304 cites W2074228821 @default.
• W2102561304 cites W2086452331 @default.
• W2102561304 cites W2093558312 @default.
• W2102561304 cites W2112092468 @default.
• W2102561304 cites W2128635872 @default.
• W2102561304 cites W2130381741 @default.
• W2102561304 cites W2135935949 @default.
• W2102561304 cites W2144075705 @default.
• W2102561304 cites W2147271502 @default.
• W2102561304 cites W2157337277 @default.
• W2102561304 cites W2162020175 @default.
• W2102561304 cites W2202479314 @default.
• W2102561304 cites W2342676081 @default.
• W2102561304 doi "https://doi.org/10.1042/bj20020801" @default.
• W2102561304 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1222927" @default.
• W2102561304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12139489" @default.
• W2102561304 hasPublicationYear "2002" @default.
• W2102561304 type Work @default.
• W2102561304 sameAs 2102561304 @default.
• W2102561304 citedByCount "69" @default.
• W2102561304 countsByYear W21025613042012 @default.
• W2102561304 countsByYear W21025613042013 @default.
• W2102561304 countsByYear W21025613042014 @default.
• W2102561304 countsByYear W21025613042015 @default.
• W2102561304 countsByYear W21025613042016 @default.
• W2102561304 countsByYear W21025613042018 @default.
• W2102561304 countsByYear W21025613042019 @default.
• W2102561304 countsByYear W21025613042021 @default.
• W2102561304 countsByYear W21025613042022 @default.
• W2102561304 crossrefType "journal-article" @default.
• W2102561304 hasAuthorship W2102561304A5000430366 @default.
• W2102561304 hasAuthorship W2102561304A5007946879 @default.
• W2102561304 hasAuthorship W2102561304A5013852274 @default.
• W2102561304 hasAuthorship W2102561304A5049208861 @default.
• W2102561304 hasAuthorship W2102561304A5066790265 @default.
• W2102561304 hasAuthorship W2102561304A5086799202 @default.
• W2102561304 hasBestOaLocation W21025613042 @default.
• W2102561304 hasConcept C104317684 @default.
• W2102561304 hasConcept C118892022 @default.
• W2102561304 hasConcept C121608353 @default.
• W2102561304 hasConcept C153911025 @default.
• W2102561304 hasConcept C2778397455 @default.
• W2102561304 hasConcept C2781320022 @default.
• W2102561304 hasConcept C2781382166 @default.
• W2102561304 hasConcept C501734568 @default.
• W2102561304 hasConcept C54355233 @default.
• W2102561304 hasConcept C86803240 @default.
• W2102561304 hasConceptScore W2102561304C104317684 @default.
• W2102561304 hasConceptScore W2102561304C118892022 @default.
• W2102561304 hasConceptScore W2102561304C121608353 @default.
• W2102561304 hasConceptScore W2102561304C153911025 @default.
• W2102561304 hasConceptScore W2102561304C2778397455 @default.
• W2102561304 hasConceptScore W2102561304C2781320022 @default.
• W2102561304 hasConceptScore W2102561304C2781382166 @default.
• W2102561304 hasConceptScore W2102561304C501734568 @default.
• W2102561304 hasConceptScore W2102561304C54355233 @default.
• W2102561304 hasConceptScore W2102561304C86803240 @default.
• W2102561304 hasIssue "3" @default.
• W2102561304 hasLocation W21025613041 @default.
• W2102561304 hasLocation W21025613042 @default.
• W2102561304 hasLocation W21025613043 @default.
• W2102561304 hasLocation W21025613044 @default.
• W2102561304 hasOpenAccess W2102561304 @default.

• next